Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Zynerba Pharmaceuticals, Inc. (ZYNE) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Zynerba Pharmaceuticals, Inc. (ZYNE) lobbying for?
Summary:
Zynerba Pharmaceuticals, Inc. hired lobbying firms Watkins & Eager Pllc and Buchanan Ingersoll & Rooney Pc to lobby on general issues related to health, pharmacy, and government. Specifically, their lobbying efforts focused on setting up meetings and calls with members of Congress, encouraging favorable action on matters important to Zynerba, identifying testing sites, and working on a trial study for a medication that could benefit individuals with fragile x syndrome. They lobbied government agencies including the Senate, FDA, and House of Representatives.
Inference:
One could infer that Zynerba Pharmaceuticals, Inc. is lobbying on health and pharmacy-related issues to advocate for their products or services to Congress, and potentially influence FDA policies and regulations that affect their business. Their focus on identifying testing sites and conducting a trial study for a medication that could benefit individuals with fragile x syndrome suggests that they are invested in providing solutions for individuals with medical needs. The specific lobbying efforts around setting up meetings with members of Congress and encouraging favorable actions on matters important to Zynerba may suggest that they are seeking to gain support from legislators and potentially influence policy changes or funding opportunities.
